2m 2m 2m 2m 2m 2m 2m
GAIN THERAPEUTIC (GANX)
NASDAQ
$1.81+$0.04 (+2.49%)
Price as of Jun 23, 2026 5:40 PM EDT- $78.9MMarket Cap
- -1.12%1-Year Change
- BiotechnologyIndustry
GAIN THERAPEUTIC (GANX)
$1.81+$0.04 (+2.49%)
GANX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.77 | ||
Change | -$0.08 (-4.32%) | ||
Open | $1.83 | ||
High | $1.90 | ||
Low | $1.77 | ||
Previous Close | $1.85 | ||
Volume | 378,818 | ||
30-Day Average Volume | 702,400 | ||
1-Week Change | -1.12% | ||
1-Month Change | -0.56% | ||
1-Year Change | -1.12% | ||
3-Year Change | -60.67% | ||
5-Year Change | -80.68% | ||
Fundamentals | |||
Shares Outstanding | 42.7M | ||
Total Assets | $18.7M | ||
Market Cap | $78.9M | ||
Enterprise Value | $62.7M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$5.6M | ||
Free Cash Flow | -$4.7M | ||
EBIT | -$5.4M | ||
EBITDA | -$5.4M | ||
Net Working Capital | $14.3M | ||
EPS | -$0.13 | ||
Enterprise Value/EBITDA | -12 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 6 | ||
P/E | -14 | ||
PEG | 2 | ||
Price/Free Cash Flow | -17 | ||
Price/Operating Cash Flow | -17 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue